Currently accepted at: Journal of Medical Internet Research
Date Submitted: Aug 5, 2026
Date Accepted: Nov 19, 2026
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/108887
The final accepted version (not copyedited yet) is in this tab.
The Research-Implementation Gap in Digital Therapeutics Economic Value: Mixed Methods Study
ABSTRACT
Background:
Digital health solutions, and digital therapeutics (DTx) in particular, face a persistent research-implementation gap, to which divergent conceptualizations of economic value across the research and implementation worlds may contribute. Members of these groups operate with differing frameworks for what economic value means, when it becomes relevant, and who is responsible for generating it across the DTx lifecycle. This conceptual misalignment, rather than a lack of intent or evidence, is a candidate explanation for limited adoption at scale.
Objective:
This study examined the extent to which researchers and those who implement DTx in practice agree on how to demonstrate its economic value, what that agreement and the points where it breaks down reveal whether the resulting concept maps can serve as a boundary object between the two groups, and what practices would be needed to strengthen that role.
Methods:
An integrated mixed methods design was employed, combining Group Concept Mapping (GCM), Procrustes analysis, and focus group discussions (FGDs). Thirty-seven participants, 18 researchers and 19 involved in implementing DTx in practice, sorted and rated 59 factors influencing DTx economic value. Procrustes analysis with permutation-based significance testing quantified structural alignment between the two resulting point maps, with residual clusters identifying zones of convergence and divergence. Two FGDs (n=5 and n=7) with individuals having at least five years of direct professional experience in DTx contextualized and extended the quantitative findings and appraised the concept maps against the five properties of boundary objects defined by Star and Griesemer.
Results:
Procrustes analysis revealed that 34 of 59 factors (58%) were positioned with near-identical spatial logic across both participants’ groups, concentrated in clinical and economic fundamentals. Divergence was concentrated toward the later stages of the lifecycle, with three residual clusters falling in the high relative divergence zone, in implementation and adoption domains. FGD participants’ accounts supported interpretive flexibility, dual structure, and robustness as present boundary object properties, while the mediating function and liminal nature received only partial or preliminary support, bounded by the facilitated research setting.
Conclusions:
The GCM concept maps demonstrate properties consistent with a designated, or candidate, boundary object and show preliminary evidence of a mediating function within facilitated cross-world deliberation; whether they become boundary objects-in-use required demonstration in actual DTx development and implementation settings. By locating precisely where shared understanding between the two worlds holds and where it is strained, the study reframes the research-implementation gap as a compelling coordination opportunity, identifying where deliberate alignment efforts would be most consequential for DTx to generate and demonstrate economic value at scale. Methodologically, it extends GCM with a quantitative diagnostic of agreement between the two groups at factor and residual cluster level, offering a transferable approach for diagnosing boundary problems in digital health innovation.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.